Research revealed – Corona vaccine can give relief to cancer victims

0
999

According to a research, corona vaccine has been found to be effective in patients suffering from cancer. Three to four weeks after the second dose of the vaccine, the immune response to corona was found to be substantially better in about 95 percent of cancer patients.

Washington. The vaccine developed to protect against Coronavirus is showing positive results in cancer patients, which is good news for people suffering from this incurable disease. This has been revealed in the results of studies conducted on patients suffering from this disease. According to the study, corona vaccine has been found to be effective in patients suffering from cancer. Three to four weeks after the second dose of the vaccine, the immune response to corona was found to be substantially better in about 95 percent of cancer patients. Researchers of Indian origin are also in the group of researchers who did this study.

According to the study published in the journal Cancer Cell, this research was done on 131 cancer patients. In this, the participants were examined after both doses of the vaccine were administered. Of these, the presence of antibodies was found in about 95 percent of the participants, while antibodies were not formed in seven cancer patients whose condition is critical. The average age of the participants in this study was 63 years.

On the other hand, researchers at the University of Copenhagen are focusing on the membrane of the cancer cell. The Faculty of Health and Medical Sciences has come up with a novel method that will repair the damage through the cancer cell itself.

, researcher Dimpy P Shah of the University of Texas Health Science Center in America said, ‘Corona in patients suffering from severe cancer No antibodies were found against the virus. According to the researchers, the study did not test other variants, including the delta of the corona. They also did not analyze the response of T cells and B cells to infection in cancer patients.